Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Journal of Cellular Physiology|March 1, 1992
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell linesE W Thompson, S Paik, N Brünner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 21, 2010
Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancerC Frederiksen, C Qvortrup, I J Christensen, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 8, 2004
Combined effects of tamoxifen and a chimeric humanized single chain antibody against the type I IGF receptor on breast tumor growth in vivoJ-J Ye, S-J Liang, N Guo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1995
Prognostic significance of the receptor for urokinase plasminogen activator in breast cancerJ Grøndahl-Hansen, H A Peters, W L van Putten, et al.
British Journal of Cancer|October 19, 2006
TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosisM L Davidsen, S Ø Würtz, M U Rømer, et al.
Clinical & Experimental Metastasis|April 7, 2004
Measurement of tumor load and distribution in a model of cancer-induced osteolysis: a necessary precaution when testing novel anti-resorptive therapiesR Nic Amhlaoibh, P Hoegh-Andersen, N Brünner, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|February 17, 1998
Effect of NCAM-transfection on growth and invasion of a human cancer cell lineK Edvardsen, E Bock, S Jirus, et al.
Oncology Reports|June 10, 2005
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaborationN Grebenchtchikov, T M Maguire, R Riisbro, et al.
European Journal of Cancer (Oxford, England : 1990)|July 1, 1996
Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): report of an EORTC/BIOMED-1 workshopT J Benraad, J Geurts-Moespot, J Grøndahl-Hansen, et al.
British Journal of Cancer|July 5, 2001
Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumoursJ H de Witte, J A Foekens, N Brünner, et al.
Pageof 15